6630--Biopool US, Inc., dba Trinity Biotech Distribution 36F79724D0149 | Cost-Per-Test (66 III) | Period of Performance 07/15/2024 - 07/14/2029
Veterans Affairs · NAC FEDERAL SUPPLY SCHEDULE (36F797)
No listed company matched (Materiality N/A)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation RFP797FSS030001R1 in this department, oldest first.
- Jul 12, 2024Award NoticeBIOPOOL U.S., INC. · $4.0MOpen
- Oct 20, 2025 · this noticeAward NoticeBIOPOOL U.S., INC. · $4.0M
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Note the winner and the end of the period of performance for the recompete.
- Follow the agency to see the next notice for this work.
Who won similar work
21 award notices on SAM.gov in the last 24 months. Matched by: Same agency (Veterans Affairs), same product/service code (PSC) 6630.
Single-winner award sizes (21): middle half $50K to $647K, median $368K; range $27K to $10.0M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| ROCHE DIAGNOSTICS CORPORATION | 4 | $1.5M | Apr 27, 2026 |
| BECKMAN COULTER, INC | 3 | $10.6M | Oct 2, 2026 |
| GOVERNMENT SCIENTIFIC SOURCE INC | 2 | $2.3M | Sep 23, 2025 |
| DIASORIN INC | 1 | $10.0M | Apr 18, 2025 |
| THERMO ELECTRON NORTH AMERICA LLC · $TMO · $46.3B | 1 | $489K | May 22, 2025 |
| ABBOTT LABORATORIES INC. · $ABT · $45.1B | 1 | $420K | Apr 4, 2025 |
| WATERS TECHNOLOGIES CORPORATION | 1 | $368K | Jul 9, 2026 |
| AGILENT TECHNOLOGIES INC · $A · $7.4B | 1 | $150K | Oct 29, 2025 |
| BECTON, DICKINSON AND COMPANY | 1 | $68K | Apr 10, 2026 |
| QUIDELORTHO SALES COMPANY | 1 | $55K | Oct 1, 2026 |
Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Notices whose amount is a placeholder such as $999,999,999 are not added in. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.
- $TMO reported $46.3B revenue (12 months to Jun 27, 2026). The median single-winner award in these 21 past awards, $368K, is under 0.1% of that. SEC filing
- $ABT reported $45.1B revenue (12 months to Mar 31, 2026). The median single-winner award in these 21 past awards, $368K, is under 0.1% of that. SEC filing
- $A reported $7.4B revenue (12 months to Jul 31, 2026). The median single-winner award in these 21 past awards, $368K, is under 0.1% of that. SEC filing
One award's total value against one year of revenue; many awards are paid over several years.
- Oct 2, 2026BECKMAN COULTER, INC$6.1M6630--Lab Testing Services for Wilkes-Barre VAMC, PANo listed company matched (Materiality N/A)
- Oct 1, 2026QUIDELORTHO SALES COMPANY$55KFY27: 6 MON BRIDGE Ortho Clinical-Pathology & LabMateriality: <0.01% of $QDEL revenue (Low) SEC
- Jul 9, 2026WATERS TECHNOLOGIES CORPORATION$368K6630--SOLE SOURCE Waters Technologies Mass SpectrometerNo listed company matched (Materiality N/A)
- Jun 25, 2026CHEMTRAC LLC$28K6630--Chemtrac Probes Purchase - STCNo listed company matched (Materiality N/A)
- Apr 27, 2026ROCHE DIAGNOSTICS CORPORATION$46KAward Notice - Ventena BenchMark Special Stainer SupplyNo listed company matched (Materiality N/A)
- Apr 10, 2026BECTON, DICKINSON AND COMPANY$68KAward Notice - BD BioscienceMateriality: <0.01% of $BDX revenue (Low) SEC
- Mar 4, 2026BIOMERIEUX INC$50K6630--Biofire ModulesNo listed company matched (Materiality N/A)
- Feb 20, 2026TOSOH BIOSCIENCE, INC.$27K6630--Cost Per Reportable Result (CPRR) HbA1c Testing - Base 4 Chillicothe VAMCNo listed company matched (Materiality N/A)
- Oct 29, 2025AGILENT TECHNOLOGIES INC$150K6630--Washington DC VAMC - Base Plus Four Option Year Contract for Immunohistochemistry CPT Reagents and SuppliesMateriality: <0.01% of $A revenue (Low) SEC
- Sep 23, 2025GOVERNMENT SCIENTIFIC SOURCE INC$55K6630--Tissue Processor | Tulsa, OK | 623No listed company matched (Materiality N/A)
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 2 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (7 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- $88K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 8 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 3 of the past winners are listed companies
- 0 insider buys and 10 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.